Description
SWOT ANALYSIS OF ASTELLAS PHARMA
Astellas Pharma
Parent Company
Astellas Pharma
Category
Pharmaceuticals
Sector
Healthcare
Tagline/ Slogan
Leading light for life; Changing tomorrow
They are research driven organization operating in over 40 countries USP with thrust on ethical pharmaceuticals.
STP
Segment
Urology, organ transplant, infection, immunology segment
Target Group
Medical representatives, healthcare professionals
They want to contribute in improving health of people through Positioning innovative & reliable healthcare
SWOT Analysis
1. Strong product pipeline supported by a workforce of over 14,000 2. Astellas pharma has management policies with strong emphasis on CSR 3. Considerable presence in organ transplant segment 4. Well defined global compliance structure which reduces regulatory issues 5. Presence in approx 15 countries 6. Expertise R&D in infectious diseases, diabetes, gastrointestinal Strength diseases etc
1. Limited presence in emerging markets and overdependence on the Japanese market Weakness 2.High reliance on few blockbuster drugs like Prograf, Harrnal, Vesicare
1. Increasing global ageing population 2. Increase in health awareness Opportunity 3. Tie-ups with global pharma brands and hospitals
Threats
1. Natural disasters in Japan which disrupts major business operations
2. Reduction in spending on healthcare 3. Global economic slowdown
Competition
1. Abbott laboratories 2. Amgen Competitors 3. Allergan Inc.
doc_460913367.docx
SWOT ANALYSIS OF ASTELLAS PHARMA
Astellas Pharma
Parent Company
Astellas Pharma
Category
Pharmaceuticals
Sector
Healthcare
Tagline/ Slogan
Leading light for life; Changing tomorrow
They are research driven organization operating in over 40 countries USP with thrust on ethical pharmaceuticals.
STP
Segment
Urology, organ transplant, infection, immunology segment
Target Group
Medical representatives, healthcare professionals
They want to contribute in improving health of people through Positioning innovative & reliable healthcare
SWOT Analysis
1. Strong product pipeline supported by a workforce of over 14,000 2. Astellas pharma has management policies with strong emphasis on CSR 3. Considerable presence in organ transplant segment 4. Well defined global compliance structure which reduces regulatory issues 5. Presence in approx 15 countries 6. Expertise R&D in infectious diseases, diabetes, gastrointestinal Strength diseases etc
1. Limited presence in emerging markets and overdependence on the Japanese market Weakness 2.High reliance on few blockbuster drugs like Prograf, Harrnal, Vesicare
1. Increasing global ageing population 2. Increase in health awareness Opportunity 3. Tie-ups with global pharma brands and hospitals
Threats
1. Natural disasters in Japan which disrupts major business operations
2. Reduction in spending on healthcare 3. Global economic slowdown
Competition
1. Abbott laboratories 2. Amgen Competitors 3. Allergan Inc.
doc_460913367.docx